Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bossuyt

Showing results (41-50 of 950) with videos related to

Pageof 95
Sort By:
Human Genetics|April 14, 2011
Genomic markers to tailor treatments: waiting or initiating?Parvin Tajik, Patrick M Bossuyt
Acta Stomatologica Belgica|September 1, 1993
[The plunging ranula: a case report]D De Coster, M Bossuyt
EJIFCC|September 30, 2016
Evaluating Biomarkers for Guiding Treatment DecisionsPatrick M Bossuyt, Tajik Parvin
Acta Stomatologica Belgica|January 1, 1982
[Surgical management of recurrent luxations and subluxations of the temporomandibular joint]G De Troyer, M Bossuyt
Cancer Epidemiology|July 31, 2012
Cancer risk models and preselection for screeningInge Stegeman, Patrick M Bossuyt
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 2, 2007
Letter to the Editors: From innumeracy to insight: the uncertainty of help versus harm in treatment of asymptomatic aortic aneurysmsD A Legemate, P M Bossuyt
Nederlands Tijdschrift Voor Geneeskunde|May 16, 2007
[The increased availability of self-tests for medical analyses]M Deutekom, P M M Bossuyt
Journal of Tropical Pediatrics|February 1, 1987
Long-term follow-up of severe protein-energy malnutrition in Eastern ZaïreP Hennart, D Beghin, M Bossuyt
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 4, 2009
Additional patient outcomes and pathways in evaluations of testingPatrick M M Bossuyt, Kirsten McCaffery
Haemostasis|March 17, 2001
Does low-molecular-weight heparin reduce the costs of venous thromboembolism treatment?P M Bossuyt, M H Prins
Pageof 95

Showing results (41-50 of 950) with videos related to

Sort By:
Pageof 95
Human Genetics|April 14, 2011
Genomic markers to tailor treatments: waiting or initiating?Parvin Tajik, Patrick M Bossuyt
Acta Stomatologica Belgica|September 1, 1993
[The plunging ranula: a case report]D De Coster, M Bossuyt
EJIFCC|September 30, 2016
Evaluating Biomarkers for Guiding Treatment DecisionsPatrick M Bossuyt, Tajik Parvin
Acta Stomatologica Belgica|January 1, 1982
[Surgical management of recurrent luxations and subluxations of the temporomandibular joint]G De Troyer, M Bossuyt
Cancer Epidemiology|July 31, 2012
Cancer risk models and preselection for screeningInge Stegeman, Patrick M Bossuyt
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 2, 2007
Letter to the Editors: From innumeracy to insight: the uncertainty of help versus harm in treatment of asymptomatic aortic aneurysmsD A Legemate, P M Bossuyt
Nederlands Tijdschrift Voor Geneeskunde|May 16, 2007
[The increased availability of self-tests for medical analyses]M Deutekom, P M M Bossuyt
Journal of Tropical Pediatrics|February 1, 1987
Long-term follow-up of severe protein-energy malnutrition in Eastern ZaïreP Hennart, D Beghin, M Bossuyt
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 4, 2009
Additional patient outcomes and pathways in evaluations of testingPatrick M M Bossuyt, Kirsten McCaffery
Haemostasis|March 17, 2001
Does low-molecular-weight heparin reduce the costs of venous thromboembolism treatment?P M Bossuyt, M H Prins
Pageof 95